financetom
Business
financetom
/
Business
/
VG Siddhartha considering selling stake in Mindtree
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VG Siddhartha considering selling stake in Mindtree
Jun 1, 2018 8:13 AM

VG Siddhartha, the founder of Coffee Day Ltd, is exploring options to monetise his stake in Bengaluru-based Mindtree, sources privy to the developments told CNBC-TV18.

Siddhartha's total shareholding in the mid-sized technology services firm comes to 20.45%, where he directly owns 3.34%, a 10.65% stake through Coffee Day Enterprises Ltd and 6.46% through Coffee Day Trading Ltd.

He is looking to sell anywhere between 5% and 10% stake in Mindtree, sources told CNBC-TV18.

The final decision will be taken by Siddhartha based on his financial plans.

Both Mindtree and Siddhartha did not offer any comment on CNBC-TV18's query.

Earlier, Siddhartha had stepped down as the independent director from the board of Mindtree.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Walmart Insider Sold Shares Worth $403,840, According to a Recent SEC Filing
Walmart Insider Sold Shares Worth $403,840, According to a Recent SEC Filing
Aug 21, 2025
05:23 PM EDT, 08/21/2025 (MT Newswires) -- Kathryn J. McLay, Executive Vice President, on August 19, 2025, sold 4,000 shares in Walmart ( WMT ) for $403,840. Following the Form 4 filing with the SEC, McLay has control over a total of 1,052,455 common shares of the company, with 1,052,455 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/104169/000179457325000008/xslF345X05/wk-form4_1755810950.xml ...
Vanda Asks FDA Commissioner to Review Decision to Uphold Approval of Two Generic Versions of Hetlioz Drug
Vanda Asks FDA Commissioner to Review Decision to Uphold Approval of Two Generic Versions of Hetlioz Drug
Aug 21, 2025
05:24 PM EDT, 08/21/2025 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said late Thursday it has asked the US Food and Drug Administration commissioner Martin Makary to review the decision by the outgoing director of Center for Drug Evaluation and Research, Jacqueline Corrigan-Curay, that upholds approval of two generic versions of the Hetlioz drug. Hetlioz is used to treat...
Cycurion Regains Nasdaq Compliance With Equity Requirement
Cycurion Regains Nasdaq Compliance With Equity Requirement
Aug 21, 2025
05:22 PM EDT, 08/21/2025 (MT Newswires) -- Cycurion ( CYCU ) said late Thursday it regained compliance with Nasdaq's stockholders' equity requirement for continued listing. Cycurion ( CYCU ) reported stockholders' equity of $10.4 million in its filing for the period ended June 30, surpassing the $10 million minimum threshold. The company said it received notification on Tuesday from Nasdaq...
--Parker-Hannifin Increases Stock Buyback Program to 20 Million Shares
--Parker-Hannifin Increases Stock Buyback Program to 20 Million Shares
Aug 21, 2025
05:23 PM EDT, 08/21/2025 (MT Newswires) -- Parker-Hannifin ( PH ) said Thursday the board has approved a revision to the motion and technology company's existing share repurchase program, allowing up to a total of 20 million shares to be repurchased. Shares were largely flat in the afterhours activity. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved